Pneumococcal Vaccination Responses Greater in Certain Patients
Serotype-specific IgG responses to the pneumococcal vaccine Pneumovax®23 were greater in patients with subnormal IgG1 than subnormal IgG3.
Pneumonia
Poor Pneumonia Outcomes Tied to Overuse of Broad-Spectrum Antibiotics
Poor outcomes include higher mortality, longer hospital stay, and greater risk for C difficile infection.
Workplace Exposures Contribute to Burden of Respiratory Disease
Substantial contribution seen to burden of diseases including asthma, COPD, chronic bronchitis, fibrosis.
Zerbaxa Approved for Hospital-Acquired Bacterial Pneumonia
Drug previously approved for treatment of complicated intra-abdominal infections, UTIs.
Influenza Seroconversion Risk Factors in Adults Hospitalized for Pneumonia
Adults hospitalized for pneumonia who received an influenza vaccination during their stay were less likely to seroconvert if they had diabetes, bacterial detection, baseline seropositive titers for influenza B, or influenza vaccination in the previous season.
Prescription Opioids Up Pneumonia Risk in Patients With, Without HIV
Risk greatest with higher-dose opioids and opioids with immunosuppressive properties.
Child Pneumonia Rate Dropped Globally From 2000 to 2015
Number of clinical pneumonia episodes in children 5 years reduced 22% in developing countries.
New CHEST Guideline for Acute Cough Suspicious of Pneumonia or Influenza
The CHEST Expert Cough Panel agreed on cough, dyspnea, pleural pain, sweating, shivers, aches, temperature of ≥38°C, tachypnea, and new and localizing chest examination signs as clinical symptoms as criteria suggestive of pneumonia in outpatient adults.
Gap Found in Pneumoccal Vaccine Recommendations Among Primary Care Clinicians
While primary care physicians overwhelmingly recommend pneumococcal vaccines, there is a gap in their knowledge of how to implement related vaccine recommendations.
Pneumococcal H Influenzae Protein D Conjugate Vaccine Effective in Children
The burden of childhood and infant pneumonia can be effectively reduced through the use of the pneumococcal Haemophilus influenzae protein D conjugate vaccine.
Next post in Vaccine Information Center
